全文获取类型
收费全文 | 9962篇 |
免费 | 924篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 123篇 |
儿科学 | 285篇 |
妇产科学 | 247篇 |
基础医学 | 1495篇 |
口腔科学 | 203篇 |
临床医学 | 900篇 |
内科学 | 2082篇 |
皮肤病学 | 307篇 |
神经病学 | 949篇 |
特种医学 | 407篇 |
外科学 | 1441篇 |
综合类 | 154篇 |
一般理论 | 3篇 |
预防医学 | 680篇 |
眼科学 | 410篇 |
药学 | 598篇 |
中国医学 | 33篇 |
肿瘤学 | 628篇 |
出版年
2023年 | 50篇 |
2022年 | 28篇 |
2021年 | 201篇 |
2020年 | 150篇 |
2019年 | 236篇 |
2018年 | 264篇 |
2017年 | 200篇 |
2016年 | 247篇 |
2015年 | 303篇 |
2014年 | 387篇 |
2013年 | 451篇 |
2012年 | 691篇 |
2011年 | 780篇 |
2010年 | 430篇 |
2009年 | 388篇 |
2008年 | 661篇 |
2007年 | 719篇 |
2006年 | 632篇 |
2005年 | 610篇 |
2004年 | 603篇 |
2003年 | 482篇 |
2002年 | 470篇 |
2001年 | 102篇 |
2000年 | 84篇 |
1999年 | 84篇 |
1998年 | 93篇 |
1997年 | 59篇 |
1996年 | 49篇 |
1995年 | 64篇 |
1994年 | 76篇 |
1993年 | 57篇 |
1992年 | 56篇 |
1991年 | 43篇 |
1990年 | 34篇 |
1989年 | 34篇 |
1988年 | 35篇 |
1987年 | 32篇 |
1986年 | 35篇 |
1985年 | 42篇 |
1984年 | 32篇 |
1983年 | 47篇 |
1982年 | 54篇 |
1981年 | 59篇 |
1980年 | 51篇 |
1979年 | 31篇 |
1978年 | 39篇 |
1977年 | 38篇 |
1976年 | 32篇 |
1975年 | 32篇 |
1974年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
1.
Edwin van der Pol Joshua A. Welsh Rienk Nieuwland 《Journal of thrombosis and haemostasis》2022,20(1):245-251
The Extracellular Vesicle Flow Cytometry Working Group ( http://www.evflowcytometry.org ) is formed by members of the International Society for Extracellular Vesicles (ISEV), the International Society for Advancement of Cytometry (ISAC), and the International Society on Thrombosis and Haemostasis (ISTH). This working group of flow cytometry experts develops guidelines for best practices regarding flow cytometry detection of extracellular vesicles. To improve rigor and standardization, this working group published a framework outlining the minimal information to report about a flow cytometry experiment on extracellular vesicles (MIFlowCyt-EV) in the Journal of Extracellular Vesicles, the ISEV journal, in 2020. In parallel, an article explaining MIFlowCyt-EV was published in Cytometry Part A, one of the ISAC journals, and now will be introduced to the ISTH as an SSC Communication in the Journal of Thrombosis and Haemostasis. The goal of this SSC Communication is to explain why flow cytometry is becoming the instrument of choice to characterize single extracellular vesicles, the obstacles that have been identified and (mostly) overcome by developing procedures to calibrate flow cytometers, and the relevance of reporting minimal information to improve reliability and reproducibility of experiments in which flow cytometers are used for characterization of extracellular vesicles. 相似文献
2.
3.
4.
Structured data sets can be created from cytology reports without the addition of synoptic reports using either natural language processing or minor changes to laboratory information systems structure.; 相似文献
5.
Anne‐Grete Mrtson Anette Veringa Edwin R. van den Heuvel Martijn Bakker Daan J. Touw Tjip S. van der Werf Lambert F. R. Span Jan‐Willem C. Alffenaar 《Mycoses》2019,62(8):698-705
Posaconazole is indicated for prophylaxis and treatment of invasive aspergillosis. Therapeutic drug monitoring (TDM) of posaconazole is used to optimise drug exposure. The aim of this study was to analyse and describe the TDM practices and exposure of posaconazole tablets. Patients who received posaconazole for treatment or prophylaxis of fungal infections were included in the study. The following therapeutic window was defined: if concentration was low (<0.7 mg/L for prophylaxis or < 1.5 mg/L for treatment) or high (>3.75 mg/L), the hospital pharmacist provided the physician with dosage advice, which implementation to patient care was analysed. A longitudinal analysis was performed to analyse if different confounding variables had an effect on posaconazole concentrations. Forty‐seven patients were enrolled resulting in 217 posaconazole trough concentrations. A median of 3 (IQR 1‐7) samples was measured per patient. The median concentration was 1.7 mg/L (IQR 0.8‐2.7) for prophylaxis and 1.76 mg/L (IQR 1.3‐2.3) for treatment. Overall, 78 posaconazole concentrations were out of the therapeutic window. For 45 (54%) of these concentrations, a dosage change was recommended. In the longitudinal analysis, the laboratory markers and patient baseline variables did not have an effect on posaconazole concentrations. Adequate posaconazole exposure was shown in 64% (affected 28 patients) of the measured concentrations. TDM practice of posaconazole can be improved by increasing the implementation rate of dose recommendation by a multidisciplinary antifungal stewardship team. 相似文献
6.
7.
8.
9.
Prospective cohort study on the outcomes of hepatitis C virus‐related cirrhosis in South Korea 下载免费PDF全文
10.